argus

Ajanta Pharma Ltd.

NSE: AJANTPHARMINE031B0104943,571 Cr

Timeline

Time (IST)TypeMEventSrc
05 May, 03:42 pmAjanta Pharma Ltd - 532331 - Disclosure As Per Regulation 30 Of SEBI (LODR)bse
05 May, 03:39 pmAjanta Pharma Limited has informed the Exchange about General Updatesnse
05 May, 03:36 pmAjanta Pharma Ltd - 532331 - Intimation Of Grant And Cancellation Of Optionsbse
05 May, 03:25 pmAjanta Pharma Ltd - 532331 - Board Meeting Outcome for Outcome Of Board Meetingbse
05 May, 03:24 pmAjanta Pharma Ltd - 532331 - PFA Financial Results For The Quarter And Year Ended 31.03.2026bse
05 May, 03:24 pmAjanta Pharma Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
22 Apr, 08:37 amAjanta Pharma Limited has informed the Exchange about General Updatesnse
22 Apr, 08:34 amAjanta Pharma Ltd - 532331 - Exchange Intimation Pursuant To Reg 30bse
21 Apr, 03:59 pmAjanta Pharma Ltd - 532331 - Board Meeting Intimation for Board Meeting Scheduled To Be Held On 5Th May 2026.bse
07 Apr, 11:25 amYOGESH M. AGRAWAL has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
04 Apr, 04:24 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
01 Apr, 02:37 pmAjanta Pharma Ltd - 532331 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure Abse
01 Apr, 10:17 amAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
27 Mar, 05:27 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011bse
23 Mar, 06:36 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011bse
09 Mar, 08:48 amAjanta Pharma Limited has informed the Exchange about Participation in Investor Conferencense
09 Mar, 08:44 amAjanta Pharma Ltd - 532331 - Participation In Investor Conferencebse
06 Mar, 12:36 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
23 Feb, 04:18 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
17 Feb, 10:22 amAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
10 Feb, 10:22 amAjanta Pharma Limited has informed the Exchange about Rumour Verification - Regulation 30(11)nse
06 Feb, 05:31 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
05 Feb, 11:10 amAjanta Pharma Limited has informed the Exchange about Transcriptnse
05 Feb, 11:05 amAjanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
02 Feb, 10:54 amAjanta Pharma Limited has informed the Exchange about Participation in Investor Conferencense
02 Feb, 10:51 amAjanta Pharma Ltd - 532331 - Participation In Investor Conferencebse
30 Jan, 05:47 pmAjanta Pharma Limited has informed the Exchange about Link of Recordingnse
30 Jan, 05:44 pmAjanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
30 Jan, 03:22 pmAjanta Pharma Limited has informed the Exchange about General Updates- Vesting and Cash Settlement of Stock Appreciation Rights (SARs) and Cancellation of Employee Stock Options (ESOPs)nse
30 Jan, 03:09 pmAjanta Pharma Limited has informed the Exchange regarding Board meeting held on January 30, 2026.nse
30 Jan, 03:07 pmAjanta Pharma Ltd - 532331 - Board Meeting Outcome for Board Meeting Outcomebse
30 Jan, 03:03 pmAjanta Pharma Ltd - 532331 - Unaudited Financial Results For Quarter Ended 31St December 2025.bse
30 Jan, 03:03 pmAjanta Pharma Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
20 Jan, 10:23 amAjanta Pharma Limited has informed the Exchange about Rumour Verification - Regulation 30(11)nse
13 Jan, 03:53 pmAjanta Pharma Limited has informed the Exchange about Formation of Subsidiary in Irelandnse
13 Jan, 03:47 pmAjanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Acquisitionbse
12 Jan, 11:54 amAjanta Pharma Ltd - 532331 - Board Meeting Intimation for Considering Unaudited Financial Results For The Quarter Ended 31St December 2025.bse
31 Dec, 06:08 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
30 Dec, 06:03 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
23 Dec, 05:10 pmAjanta Pharma Limited has informed the Exchange regarding a press release dated December 23, 2025, titled "Press Release".nse
23 Dec, 05:07 pmAjanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
19 Dec, 12:32 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
10 Dec, 02:36 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
28 Nov, 10:04 amAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.bse
13 Nov, 03:06 pmAjanta Pharma Ltd - 532331 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011bse
06 Nov, 08:59 amAjanta Pharma Limited has informed the Exchange about Transcriptnse
06 Nov, 08:53 amAjanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Earnings Call Transcriptbse
03 Nov, 04:39 pmAjanta Pharma Limited has informed the Exchange about Link of Recordingnse
03 Nov, 04:37 pmAjanta Pharma Ltd - 532331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
03 Nov, 03:33 pmAjanta Pharma Limited has informed the Exchange regarding change in Registered Office of the company.nse